MELAS syndrome: features of diagnostics, clinical course, and treatment (clinical case)
Year: 2021, volume 17 Issue: №1 Pages: 155-159
Heading: Тhematic supplement Article type: Case report
Authors: Ulyanova O.V., Kutashov V.A.
Organization: Voronezh State Medical University n.a. N.N. Burdenko
Heading: Тhematic supplement Article type: Case report
Authors: Ulyanova O.V., Kutashov V.A.
Organization: Voronezh State Medical University n.a. N.N. Burdenko
Summary:
Purpose: to develop and propose an algorithm for timely and accessible clinical diagnostics and basic principles of treatment of patients with MELAS syndrome (one of the most common diseases in the group of mitochondrial diseases (MB)), based on the example of a specific clinical case. The prevalence of this pathology cannot be estimated due to the variety of clinical manifestations and, as a consequence, due to the complexity of timely diagnostics. Diagnosis of this disease, from the onset of the initial clinical manifestations to the clear establishment of the MELAS syndrome, often takes years. We present and discuss clear clinical criteria for making a diagnosis, as well as the features of neu-roimaging changes in the brain, which allows us to detect the disease at the earliest stage. A detailed clinical analysis of patient B.'s own observation, born in 1993, with MELAS syndrome is presented. This clinical case clearly demonstrates the emerging difficulties for the earliest diagnosis of this pathology in patients with MB. Despite the phenotypic heterogeneity of mitochondrial disorders, the relationship between clinical signs and additional laboratory data, genetic verification of the diagnosis can provide the clinician with sufficiently important information to unravel the genetic defect, which allows for an earlier diagnosis and prescribing timely treatment.
Bibliography:
1. Smirnova IN, Kistenev BA, Krotenkova MV, Suslina ZA. Stroke similar mitochondria! encephalomyopathy (MELAS syndrome). Nervous Diseases 2006; (1): 43-8.
2. El-Hattab AW, Adesina AM, Jones J, Scaglia F. MELAS syndrome: clinical manifestations, pathogenesis, and treatment options. Mol Genet Metab 2015; 116 (1-2): 4-12. DOI: 10.1016.
3. El-Hattab AW, Almannai M, Scaglia F. Arginine and citrulline for the treatment of MELAS syndrome. J Inborn Errors Metab Screen 2017 Jan 5. DOI: 10.1177/2326409817697399.
4. Murakami H, Ono K. MELAS: Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes. Brain Nerve 2017; 69 (2): 111-7. DOI: 10.11477/mf. 1416200650.
5. Lorenzoni PJ, Werneck LC, Kay CS, et al. When should MELAS (Mitochondrial myopathy, Encephalopathy
Lactic Acidosis, and Stroke-like episodes) be the diagnosis? Arq Neuropsiquiatr2015; 73 (11): 959-67. DOI: 10.1590/0004-282X20150154.
6. Yamin MA, Chernikova IV, Araslanova LV, Shevkun PA. Mitochondrial encephalopathy with stroke-like episodes and lactic acidosis (MELAS syndrome): diagnostic criteria, features of epileptic seizures and approaches to treatment based on the example of a clinical case. Neurology, Neuropsychiatry Psychosomatics 2017; 9 (4): 65-9.
7. Pizova NV. Strokes in mitochondrial disease. Neurology Neuropsychiatry, Psychosomatics 2017; 9 (4): 73-8.
8. Muranova AV, Strokov IA. Mitochondrial cytopathies: MELAS and MIDD syndromes. One genetic defect — different clinical phenotypes. Neurological Journal 2017; 22 (1): 19-24. DOI: http://dx.doi.org/10.18821/1560-9545-2017-22-1-19-24 .
9. Kalashnikova LA, Dobrynina LA, Sakharova AV, et al. Stroke-like episodes in mitochondrial encephalomyopathy with lactic acidosis. Annals of Clinical and Experimental Neurology 2010; 3: 50-8.
10. Kharlamov DA, Krapivkin Al, Sukhorukov VS, Kuftina LA. Neurological disorders in mitochondrial encephalomyopathy — lactic acidosis with stroke-like episodes (MELAS syndrome). Russian Bulletin of Perinatology and Pediatrics 2012; 4 (2): 44-50.
| Attachment | Size |
|---|---|
| 2021_01-1_155-159.pdf | 289.39 KB |
Русский
English